EU: PRIME Success For Givlaari At CHMP

EMA Panel Recommends Alnylam’s Givosiran For Approval

Concept of national healthcare system - EU - European Union
Givlaari has moved closer to Europe for patients with acute hepatic porphyria • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

More from Geography